Drugs and biologicals
Ended Purchase Order Awarded Last action
- Contract number
- 75N91020P00427
- Awardee
-
Omega Scientific, Inc. UEI G1GKVL9MAW68
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,630
Award facts
- Contract value 100% obligated
- $14,630.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Tarzana, CA 91356, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Omega Scientific, Inc. for $14,630.00 on April 29, 2020, with an ultimate completion date of May 31, 2020. The order procures drugs and biologicals on a firm fixed price basis. Performance is at Omega Scientific's facility in Tarzana, California. No small business set-aside was used.
Quick answers
Who was awarded contract 75N91020P00427?
75N91020P00427 was awarded to Omega Scientific, Inc. by National Cancer Institute (National Institutes of Health) on April 29, 2020.
How much is contract 75N91020P00427 worth?
The government has obligated $14,630 on 75N91020P00427.
Was contract 75N91020P00427 competed?
The extent of competition for 75N91020P00427 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award